LAZARD ASSET MANAGEMENT LLC - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 64 filers reported holding AUTOLUS THERAPEUTICS PLC in Q1 2023. The put-call ratio across all filers is 0.27 and the average weighting 1.1%.

Quarter-by-quarter ownership
LAZARD ASSET MANAGEMENT LLC ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$25
+4.2%
11,020
+4.4%
0.00%
Q2 2023$24
+33.3%
10,551
+3.8%
0.00%
Q1 2023$18
+157.1%
10,168
+171.0%
0.00%
Q4 2022$73,7520.00%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q1 2023
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 3,530,657$23,126,0001.85%
TFG Asset Management GP Ltd 2,500,000$16,375,0001.00%
Nantahala Capital Management 2,936,791$19,236,0000.61%
MYDA Advisors LLC 171,953$1,126,0000.32%
SABBY MANAGEMENT, LLC 300,000$1,965,0000.27%
Regency Capital Management Inc.\DE 57,000$373,0000.26%
Ikarian Capital, LLC 544,819$3,568,0000.25%
Eversept Partners, LP 398,074$2,607,3850.18%
Henry James International Management Inc. 54,047$354,0000.11%
Alphabet Inc. 698,262$4,574,0000.11%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders